From October 22–26, Telepathic Instruments takes over Filling Pieces in the heart of Amsterdam Dance Event for a five-day pop-up, where Orchid will be available to try in Europe for the first time. After two sold-out drops and the instrument’s official global launch earlier this mo.nth, this rare opportunity invites producers, artists, songwriters—and the simply curious—to discover why Orchid has become one of the most talked-about new instruments in music technology.
Conceived more than a decade ago by Kevin Parker (Tame Impala) as a personal songwriting tool, Orchid has grown into a refined, community-shaped instrument designed to help musicians find what’s on their mind. With its intuitive chord-generating interface, three synth engines, and a wide array of patterns, patches and FX, Orchid takes care of complex chord maths so artists can feel out a song, wherever it may take them.
Orchid is already shaping today’s music landscape—heard in Kid Cudi’s “Submarine” from his 2025 album Free, on Don Toliver’s “Call Back,” and in the songwriting of Janelle Monáe, Diplo, Fred Again, Joy Anonymous, Madison Beer, Logic, Mark Hoppus, Ryan Tedder, Murda Beatz, Gracie Abrams and Sara Landry, among others.
Following its first two limited releases selling out in minutes, Orchid Drop 3 launched globally on October 10, 2025, introducing new community-requested features such as beats pre-programmed by Kevin Parker, quantisation, drum FX, user sound saving, loop save + recall, and ten brand-new sounds. Drop 3 also marked the debut of Pistil, Orchid’s companion plugin, which allows two-way sync with Orchid hardware and seamless integration into DAWs.
Orchid makes its European debut within Sweat It Out’s first-ever Amsterdam Writing Camp (October 20–22), where over 47 leading international and Australian artists will collaborate across eight studios, placing the instrument at the center of ADE’s creative energy.
Be the first to know. Register here to receive updates on Telepathic Instruments at ADE.
Connect with Telepathic Instruments:
